#1 Clinical Trials Search in Europe

Aluminium Oxide, Hydrated

This article discusses clinical trials investigating the use of Aluminium Oxide, Hydrated, a component of antacid medications, in strategies to reduce or discontinue proton pump inhibitor (PPI) use in patients with heartburn, reflux, or dyspepsia. The trials aim to determine the most effective approach for stopping chronic PPI therapy in primary care patients, comparing on-demand use, alginate therapy, and gradual dose reduction.

Table of Contents

What is Aluminium Oxide, Hydrated?

Aluminium oxide, hydrated is an active ingredient commonly found in antacid medications. It is often combined with other substances, such as magnesium hydroxide, to create more effective antacid formulations[1]. These combinations are designed to neutralize stomach acid and provide relief from various digestive symptoms.

Aluminium oxide is also known by its synonym, alumina[1]. This substance, along with its combinations, belongs to a class of medications called antacids, which are used to treat various digestive issues.

Medical Uses

Aluminium oxide, hydrated, in combination with other substances, is primarily used to treat the following conditions:

  • Heartburn: A burning sensation in the chest often caused by stomach acid flowing back into the esophagus.
  • Acid reflux: A condition where stomach contents flow back into the esophagus, causing discomfort and potential damage.
  • Dyspepsia: Also known as indigestion, this is a general term for digestive discomfort, including symptoms like bloating, nausea, and upper abdominal pain.
  • Functional dyspepsia: A specific type of dyspepsia where symptoms persist but no obvious cause can be found through standard diagnostic tests[1].

These medications work by neutralizing excess stomach acid, which can help alleviate symptoms and provide relief to patients suffering from these digestive issues.

Available Formulations

Aluminium oxide, hydrated is available in various formulations, often combined with other active ingredients. Some common products include:

  • Maalox Antacid® 200 mg/400 mg chewable tablets: Contains aluminium oxide, hydrated and magnesium hydroxide[1].
  • Maalox Antacid® Lemon 230 mg/400 mg per 4.3 ml oral suspension: Contains aluminium oxide (hydrated and non-hydrated forms) and magnesium hydroxide[1].
  • Maalox Antacid® Sugar-free Lemon 200 mg/400 mg chewable tablets: Contains aluminium oxide, hydrated and magnesium hydroxide[1].

These different formulations allow patients to choose the most suitable option based on their preferences and needs.

Dosage and Administration

The dosage of aluminium oxide, hydrated products can vary depending on the specific formulation and the patient’s needs. However, based on the information provided in the clinical trial data, some general guidelines can be inferred:

  • The maximum daily dose is typically 8 units (tablets or doses of oral suspension)[1].
  • The maximum total dose over a treatment period is usually 248 units[1].
  • The maximum treatment period is generally around 31 days[1].

It’s important to note that these are general guidelines, and patients should always follow the specific instructions provided by their healthcare provider or the product label.

Deprescribing Strategies

For patients who have been using antacids or related medications like proton pump inhibitors (PPIs) for an extended period, healthcare providers may consider deprescribing strategies. These strategies aim to reduce or discontinue the use of these medications when they are no longer necessary. Some approaches being studied include:

  1. On-demand PPI use: This involves using the lowest effective dose of PPI only when symptoms occur, followed by stopping when symptoms are controlled[1].
  2. Alginate treatment: This strategy replaces PPIs with alginate formulations (like Gaviscon®) for a month before discontinuing all medication[1].
  3. Gradual dose reduction: This method involves slowly decreasing the frequency of PPI intake over a month before stopping completely[1].

These strategies are being evaluated to determine the most effective way to help patients reduce their reliance on long-term antacid or PPI use when appropriate.

Precautions and Considerations

While aluminium oxide, hydrated and related antacid products are generally considered safe, there are some important considerations:

  • These medications are typically intended for short-term use. Long-term use should be discussed with a healthcare provider[1].
  • Patients with certain conditions, such as severe esophagitis, peptic ulcers, or Barrett’s esophagus, may require different treatment approaches[1].
  • These medications may interact with other drugs, so it’s important to inform your healthcare provider about all medications you’re taking[1].
  • Pregnant or breastfeeding women should consult their healthcare provider before using these medications[1].

Always consult with a healthcare professional for personalized advice on using aluminium oxide, hydrated products or any other antacid medications.

Aspect Details
Study Type Pragmatic, open, randomized, parallel-group clinical trial
Main Objective Determine the best deprescribing strategy for proton pump inhibitors (PPIs)
Study Arms 1. On-demand PPI use
2. Alginate treatment
3. Gradually decreasing intermittent PPI dosing
Primary Endpoint Percentage of patients achieving successful therapeutic outcome at the end of follow-up
Inclusion Criteria Adults >18 years, chronic PPI use >12 weeks without clear indication
Exclusion Criteria Short-term PPI use, established long-term indications, chronic antacid use, pregnancy/lactation
Role of Aluminium Oxide, Hydrated Component of antacid medications used in deprescribing strategies
Treatment Duration Maximum 31 days for antacid medications

FAQ

  • What is the main objective of the clinical trial involving Aluminium Oxide, Hydrated? The main objective is to determine the best strategy for deprescribing proton pump inhibitors (PPIs) in patients who have been using them chronically without a clear long-term indication. The study compares on-demand PPI use, replacement with alginate formulation, and gradual dose reduction of PPIs.
  • Who is eligible to participate in this clinical trial? Eligible participants are adults over 18 years old, both male and female, who have been using PPIs daily for more than 12 weeks without a clear indication for long-term use.
  • What are the exclusion criteria for the trial? Exclusion criteria include patients on short-term PPI therapy, those unable to understand or comply with the study, patients with established long-term indications for PPI use, chronic users of certain antacids, long-term NSAID users, patients with a history of gastric or esophageal surgery, and pregnant or lactating women.
  • How is Aluminium Oxide, Hydrated used in this clinical trial? Aluminium Oxide, Hydrated is a component of antacid medications like Maalox Antacid, which may be used as part of the deprescribing strategies in the trial, particularly in the alginate treatment arm where patients replace PPIs with alginate formulations.
  • What is the duration of the treatment period in this clinical trial? The maximum treatment period for the antacid medications containing Aluminium Oxide, Hydrated is 31 days, as specified in the trial details.

Ongoing Clinical Trials on Aluminium Oxide, Hydrated

  • Study on Reducing Proton Pump Inhibitor Use in Patients with Heartburn, Reflux, or Dyspepsia: Comparing On-Demand Use, Alginate Therapy, and Gradual Dose Reduction

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Proton Pump Inhibitor (PPI): A type of medication that reduces stomach acid production, commonly used to treat conditions like heartburn, acid reflux, and ulcers.
  • Deprescribing: The process of reducing or stopping medications that may no longer be beneficial or may be causing harm, under the supervision of a healthcare professional.
  • Alginate: A substance derived from seaweed that forms a protective barrier in the stomach and esophagus, used to treat heartburn and acid reflux.
  • Functional dyspepsia: A chronic condition causing pain or discomfort in the upper abdomen, often without a clear cause.
  • On-demand use: Taking medication only when symptoms occur, rather than on a regular schedule.
  • Antacid: A medication that neutralizes stomach acid to relieve heartburn, indigestion, or stomach upset.
  • Aluminium Oxide, Hydrated: A chemical compound used in antacid medications to neutralize stomach acid and relieve symptoms of indigestion.

References

  1. http://clinicaltrials.eu/trial/study-on-reducing-proton-pump-inhibitor-use-in-patients-with-heartburn-reflux-or-dyspepsia-comparing-on-demand-use-alginate-therapy-and-gradual-dose-reduction/